J. Eron

Rodney J. Knight, M. Hudgens, M. Sandelowski, 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.

Clones of infected cells arise early in HIV-infected individuals.

S. Hughes, J. Mellors, B. Luke, 2019, JCI insight.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

N. Parkin, J. Nelson, J. V. van Oosterhout, 2009, AIDS.

Major Coexisting Human Immunodeficiency Virus Type 1 env Gene Subpopulations in the Peripheral Blood Are Produced by Cells with Similar Turnover Rates and Show Little Evidence of Genetic Compartmentalization

C. Burch, R. Swanstrom, R. Price, 2009, Journal of Virology.

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.

T. Kepler, M. Davidian, J. Frelinger, 1999, AIDS research and human retroviruses.

Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1

R. Swanstrom, J. Nelson, N. Hoffman, 2004, Journal of Virology.

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

M. Kozal, H. Günthard, S. Little, 2021, AIDS.

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.

Christopher D Pilcher, Peter A Leone, J. Eron, 2002, JAMA.

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.

Shuntai Zhou, R. Swanstrom, I. Frank, 2016, The Journal of infectious diseases.

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection

Ashley J. Mayo, H. Chu, D. Margolis, 2011, AIDS.

CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection

G. Ferrari, G. Tomaras, J. Eron, 2012, The Journal of Immunology.

CD4CD8 T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection

G. Ferrari, G. Tomaras, J. Eron, 2012 .

Acute HIV Infection Portion of the Anti-HIV T Cell Response to T Cells Represent a Significant + CD8+ CD4

G. Ferrari, G. Tomaras, J. Eron, 2012 .

Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.

Cassandra B. Jabara, Shuntai Zhou, R. Swanstrom, 2015, AIDS research and human retroviruses.

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

J. Tolson, J. Eron, P. Ruane, 2000, AIDS.

Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model

P. Sen, P. Vernazza, J. Krieger, 2001, AIDS.

Prevalence of Transmitted Antiretroviral Drug Resistance Differs Between Acutely and Chronically HIV-Infected Patients

Ann M. Dennis, C. Hurt, J. Eron, 2012, Journal of acquired immune deficiency syndromes.

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

J. Mellors, S. Holmes, R. Bosch, 2022, Frontiers in Cellular and Infection Microbiology.

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

J. Mellors, R. Bosch, R. B. Jones, 2021, AIDS.

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

J. Mellors, R. Bosch, C. Rinaldo, 2017, PLoS pathogens.

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity.

J. Frelinger, J. Eron, J. Eron, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy.

A. Adimora, D. Margolis, N. Archin, 2020, The Journal of infectious diseases.

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.

R. Swanstrom, R. Price, N. Archin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

Nancie M Archin, D. Margolis, N. Archin, 2017, The Journal of clinical investigation.

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

John W. Mellors, Robert W. Coombs, Michael M. Lederman, 2012, Journal of acquired immune deficiency syndromes.

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

B. Walker, C. Kovacs, J. Mellors, 2017, PLoS pathogens.

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

P. Hanley, C. Cruz, C. Rooney, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Comparison of methods to quantify inducible HIV-1 outgrowth

J. Mellors, J. Eron, R. Gandhi, 2021, Journal of virus eradication.

Incident Sexually Transmitted Infection as a Biomarker for High-Risk Sexual Behavior After Diagnosis of Acute HIV

J. Eron, C. Hicks, L. Hightow-Weidman, 2014, Sexually transmitted diseases.

Investigating a Sexual Network of Black Men Who Have Sex With Men: Implications for Transmission and Prevention of HIV Infection in the United States

Emily C. Pike, C. Hurt, J. Eron, 2012, Journal of acquired immune deficiency syndromes.

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

D. Richman, D. Havlir, J. Mellors, 2003, AIDS.

Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin.

A. Adimora, L. Anderson, S. Tong, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus–Exposed, Uninfected Infants in Malawi: The BAN Study

Rodney J. Knight, M. Hudgens, L. Adair, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.

J. Coffin, D. Margolis, N. Archin, 2017, AIDS research and human retroviruses.

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

J. Coffin, R. Bosch, D. Margolis, 2008, AIDS.

Acute HIV-1 infection in the Southeastern United States: a cohort study.

D. Margolis, G. Ferrari, C. Hurt, 2013, AIDS research and human retroviruses.

HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.

D. Hazuda, D. Richman, J. Coffin, 2014, The Journal of infectious diseases.

HIV in body ̄uids during primary HIV infection: implications for pathogenesis, treatment and public health

J. Eron, K. Robertsona, William C. Millera, 2022 .

Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects.

H. An, Weili Lin, W. Powers, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy

R. Siliciano, J. Mellors, R. Bosch, 2019 .

Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.

D. Rosen, D. Wohl, J. Eron, 2013, AIDS research and human retroviruses.

Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.

D. Margolis, G. Ferrari, K. Robertson, 2020, AIDS.

Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.

A. Weintrob, J. Eron, C. Hicks, 2003, Archives of internal medicine.

pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo

M. Hirsch, A. Caliendo, R. D’Aquila, 1993, Antimicrobial Agents and Chemotherapy.

HIV Antigens Can Induce TGF-β1-Producing Immunoregulatory CD8+ T Cells1

J. Frelinger, J. Eron, C. Pilcher, 2002, The Journal of Immunology.

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

F. Vaida, J. Mellors, R. Bosch, 2016, The Journal of infectious diseases.

Predictors of Residual Viremia in Patients on Long-term Suppressive Antiretroviral Therapy

J. Mellors, R. Bosch, J. Eron, 2013 .

No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART

J. Mellors, R. Bosch, C. Rinaldo, 2019, Journal of acquired immune deficiency syndromes.

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.

I. Frank, K. Mayer, C. Hendrix, 2021, AIDS.

HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells

R. Swanstrom, R. Price, J. Eron, 2023, Pathogens & immunity.

Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells

R. Swanstrom, N. Archin, K. Robertson, 2019 .

Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy.

W. Miller, J. Eron, C. Pilcher, 1999, AIDS.

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection

M. Hudgens, D. Margolis, R. Gorelick, 2020, Scientific Reports.

Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV‐1‐Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy

T. Gingeras, D. Kuritzkes, J. Eron, 2000, Journal of acquired immune deficiency syndromes.

Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.

M. Hirsch, V. Johnson, T. Chou, 1991, The Journal of infectious diseases.

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy

J. Mellors, R. Bosch, J. Eron, 2022, Journal of virus eradication.

antiviral agent that may be used in combination with antiretroviral therapy.

D. Havlir, J. Mellors, T. Akaike, 2015 .

Detection of acute infections during HIV testing in North Carolina.

William C Miller, Trang Q Nguyen, Christopher D Pilcher, 2005, The New England journal of medicine.

Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV

K. F. Moseley, D. Kuritzkes, R. Bosch, 2021, Journal of acquired immune deficiency syndromes.

Novel therapies based on mechanisms of HIV-1 cell entry.

J. Kilby, J. Eron, J. Eron, 2003, The New England journal of medicine.

Short-Cycle Therapy is Short on Ethics.

J. Sugarman, J. Eron, 2021, International journal of antimicrobial agents.

Macrophages sustain HIV replication in vivo independently of T cells.

A. Haase, J. Garcia, V. Madden, 2016, The Journal of clinical investigation.

Sexual transmission of HIV: infectiousness and prevention.

P. Vernazza, J. Eron, S. Fiscus, 1999, AIDS.

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.

S. Hammer, D. Katzenstein, S. Liou, 2001, The New England journal of medicine.

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

P. Volberding, J. Gallant, M. Saag, 2002, AIDS research and human retroviruses.

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

E A Emini, D. Richman, D. Havlir, 1997, The New England journal of medicine.

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

S. Hammer, A. Hsu, M. King, 2001, AIDS.

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.

J. Hall, J. Eron, S. Fiscus, 1999, The Journal of infectious diseases.

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

T. Merigan, G. D. Miralles, J. Bartlett, 2004, The Journal of infectious diseases.

High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa.

P. Vernazza, I. Hoffman, R. Royce, 1998, The Journal of infectious diseases.

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

D. Richman, D. Havlir, J. Mellors, 1998, JAMA.

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability

D. Margolis, G. Ferrari, J. Eron, 2016, AIDS.

HIV-1 shedding and chlamydial urethritis.

J. Eron, S. Fiscus, J. Eron, 1996, JAMA.

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection

M. Hudgens, D. Margolis, R. Gorelick, 2020, Scientific Reports.

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

Joel E Gallant, Calvin Cohen, Edwin DeJesus, 2003, AIDS.

Curing HIV: Seeking to Target and Clear Persistent Infection

R. Swanstrom, D. Margolis, G. Ferrari, 2020, Cell.

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

J. Eron, J. Eron, S. Gotzkowsky, 2002, The Journal of infectious diseases.

A novel codon insert in protease of clade B HIV type 1.

D. Richman, K. Squires, C. Ignacio, 2009, AIDS research and human retroviruses.

Macrophages sustain HIV replication in vivo independently of T cells.

A. Haase, V. Madden, J. Eron, 2016, The Journal of clinical investigation.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell Activation

D. Margolis, M. Vinikoor, J. Eron, 2013, Journal of acquired immune deficiency syndromes.

Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi.

P. Vernazza, I. Hoffman, P. Kazembe, 1998, The Journal of infectious diseases.

Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.

Cassandra B. Jabara, Shuntai Zhou, R. Swanstrom, 2015, AIDS research and human retroviruses.

CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection

G. Tomaras, J. Eron, C. Hicks, 2012, Journal of Immunology.

Novel therapies based on mechanisms of HIV-1 cell entry.

J. Kilby, J. Eron, 2003, The New England journal of medicine.

Sexually transmitted infections among patients with acute HIV in North Carolina.

J. Eron, S. Fiscus, J. Kuruc, 2009, Sexually transmitted diseases.

Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1

J. Eron, J. Eron, A. Kashuba, 1999, Antimicrobial Agents and Chemotherapy.

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

M. Hughes, E. Daar, Davey M. Smith, 2022, Cell Reports Medicine.

Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.

J. Eron, S. Fiscus, J. Eron, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.